Molecular floats with CHF 482m market cap
Swiss venture capital-backed biotech Molecular Partners listed on the Swiss Exchange yesterday with a market cap of CHF 482m.
More on DACH
Adiuva's Konzmann bolts on TCon, HSV
Rehms Building Technology has sold the businesses as part of its self-administration proceedings
Cornerstone Capital exits EppsteinFoils to trade
GP invested in the metal foils producer, then known as Stanniolfabrik Eppstein, in 2008
Amplify raises $375m across two funds
Amplify IV targets seed and series-A rounds, while Amplify Select makes follow-on investments in existing portfolio companies
VC-backed Limehome increases series-A by €10m
Accommodation booking site raised €21m from HV Holtzbrinck, Lakestar and Picus Capital in February
Latest News
Agilitas-backed Danoffice to buy NPVision
Deal will be the second add-on acquisition for Danoffice since Agilitas's buyout of the company in November 2017
Bowmark acquires Totalmobile from Horizon
Bowmark will provide additional funding of £100m to fund the company's add-ons acquisitions
Carlyle buys Calastone from Accel, Octopus
Exit represents an 18x return on Octopus's initial investment and a 9x return on its total investment
Nordian Capital completes J-Club acquisition
Deal follows M&A litigation initiated after coronavirus uncertainty and financing difficulties